SCHEMBL2152132

SCHEMBL2152132

CCOC(=O)c1cn(-c2cccc(OCC)c2)c(-c2ccc(F)cc2F)n1

nearest known ligand 0.66

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CCKAR P32238 12/20 0.66
GABRA2 P47869 6/20 0.54
GABRB2 P47870 6/20 0.54
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2152281 0.92 CCKAR (0.66) CCKARGABRA2GABRB2
SCHEMBL2152391 0.91 CCKAR (0.67) CCKAR
SCHEMBL2152511 0.87 GABRA2 (0.73) CCKARGABRA2GABRB2
SCHEMBL2152558 0.83 CCKAR (0.67) CCKAR
SCHEMBL3133604 0.80 CCKAR (1.00) CCKAR
SCHEMBL2152521 0.80 GABRA2 (0.75) CCKARGABRA2GABRB2
SCHEMBL28780786 0.80 CCKAR (0.55) CCKAR
SCHEMBL2152185 0.80 CCKAR (0.64) CCKARGABRA2GABRB2
SCHEMBL1437401 0.78 GABRA2 (0.73) CCKARGABRA2GABRB2
SCHEMBL2152244 0.78 CCKAR (0.81) CCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977339-B2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators MERCK SHARP & DOHME CORP. (US) 2011-07-12 US disclosed
EP-2010519-B1 SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS MERCK SHARP & DOHME (US) 2011-07-06 EP disclosed
US-20100311649-A1 SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. (US) 2010-12-09 US disclosed
US-7795265-B2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators MERCK SHARP & DOHME CORP. (US) 2010-09-14 US disclosed
US-7759352-B2 Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulators MERCK SHARP & DOHME CORP. (US) 2010-07-20 US disclosed
EP-2010179-B1 SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS MERCK SHARP & DOHME (US) 2010-07-07 EP disclosed
US-20090281117-A1 Substituted Imidazole-4-Carboxamides as Cholecystokinin -1 Receptor Modulators MERCK SHARP & DOHME CORP. 2009-11-12 US disclosed
US-20090118300-A1 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators MERCK SHARP & DOHME LLC 2009-05-07 US disclosed
EP-2010519-A2 SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS Merck & Co., Inc. (US) 2009-01-07 EP disclosed
WO-2007120655-A2 SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS MERCK & CO., INC. (US) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118300-A1 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators CCKAR, CCKBR, GPR119 CCKAR 1/4885GABRA2 447/4885GABRB2 314/4885
US-20090281117-A1 Substituted Imidazole-4-Carboxamides as Cholecystokinin -1 Receptor Modulators CCKAR, CCKBR, GPR119 CCKAR 1/4885GABRA2 419/4885GABRB2 308/4885
US-20100311649-A1 SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS CCKAR, CCKBR, GPR119 CCKAR 1/4885GABRA2 447/4885GABRB2 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.